Sabindra Pradhananga, William Salvail, Eric Campeau, Dinesh Srinivasan, Marc Vidal, Paul Truex, Debra Odink, Saumya Das, Amy Sehnert. "Abstract 4369238: THRV-1268, a potent and selective serum and glucocorticoid regulated kinase (SGK1) inhibitor, improves adverse cardiac remodeling better than Jardiance® (empagliflozin), a sodium-glucose cotransporter 2 (SGLT2) inhibitor in heart failure." Circulation, 2025. doi:10.1161/circ.152.suppl_3.4369238